πŸ“Š Post – Market Report- September 29, 2025

πŸŒ† Indian Stock Market Closing Highlights The Indian stock market ended flat to slightly negative on Monday, September 29, 2025, as investors turned cautious ahead of the RBI Monetary Policy Committee (MPC) meeting. Despite global optimism and strength in select sectors like PSU banks and oil & gas, the indices failed to sustain higher levels […]

πŸ“Š Post – Market Report- September 29, 2025 Read More Β»

🏁 Pre- Market Report- 29 September 2025

🌍 Global Cues Overnight, U.S. markets closed higher, bolstered by optimism over future rate cuts and easing trade fears. In Asia, mixed action persists β€” some markets rallying on global cues, others holding back on macro uncertainties. One key point: India VIX surged ~6% to ~11.42 in early trade previews, showing that market participants are

🏁 Pre- Market Report- 29 September 2025 Read More »

πŸ—“ Indian Stock Markets weekly Performance Report.

This week Indian equities ended widespread weakness. About 440 Stocks ended in Red in BSE 500 index and 17 Stocks dropped more than 10% in the week. In IT and Pharma sectors the pressure was continued. Which underperformed sharply and dragged down broader indices. Markets hit multi-week lows,confirming that the recent downtrend is not just

πŸ—“ Indian Stock Markets weekly Performance Report. Read More Β»

πŸ“ˆ Two Growth Stocks Fundamentals and Technical Details.

 1. Larsen & Toubro (L&T) 🧾 Fundamentals Analysis Sector: Infrastructure and Engineering. Market Capitalisation: β‚Ή4.5 Lakh crore PE Ratio: 19.2 ROE: 18% Dividend Yield: 1.2% Debt-to-equity ratio:0.5 L&T is diversified conglomerate with a strong presence in engineering, construction and technology sectors. The company has a robust order book and is well-positioned to benefit from increased infrastructure

πŸ“ˆ Two Growth Stocks Fundamentals and Technical Details. Read More Β»

πŸ“‰ Post-Market Report – 26 September 2025

🌍 Global & Macro Overview Markets globally were jittery today, with fresh U.S. tariff announcements weighing heavily on investor sentiment. The pharma sector in India was hit hard after news of steep import duties on branded drugs triggered sharp selloff in related names. Meanwhile, continued foreign capital outflows exerted additional pressure on the domestic equity

πŸ“‰ Post-Market Report – 26 September 2025 Read More Β»